Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Alonci

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|September 1, 1996
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment responseC Musolino, A Alonci, A Allegra, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2016
Methimazole-Induced Agranulocytosis and Quick Recovery with G-CSFL Calabrò, A Alonci, G Bellomo, et al.
Hematological Oncology|May 28, 2008
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseasesA Alonci, A Allegra, G Bellomo, et al.
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques|August 1, 1990
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myelomaC Musolino, A Allegra, A Orlando, et al.
Medical Oncology (Northwood, London, England)|December 17, 2009
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemiaA Alonci, A Allegra, G Bellomo, et al.
American Journal of Hematology|May 1, 1993
Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemiaC Musolino, P Grosso, A Alonci, et al.
American Journal of Hematology|May 1, 1994
Effective therapy of aplastic anaemia post-hepatitis with recombinant human erythropoietinC Musolino, A Orlando, A Alonci, et al.
Journal of Neurosurgical Sciences|March 1, 1994
Combined systemic beta-interferon and thymostimulin administration for metastatic brain tumors. A brief reportF M Salpietro, S Cipri, C Alafaci, et al.
Acta Haematologica|January 1, 1991
Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemiaC Musolino, E Di Cesare, A Alonci, et al.
European Journal of Cancer Care|July 4, 2017
Standardisation of minimal residual disease in multiple myelomaV Innao, A Allegra, S Russo, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|September 1, 1996
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment responseC Musolino, A Alonci, A Allegra, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2016
Methimazole-Induced Agranulocytosis and Quick Recovery with G-CSFL Calabrò, A Alonci, G Bellomo, et al.
Hematological Oncology|May 28, 2008
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseasesA Alonci, A Allegra, G Bellomo, et al.
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques|August 1, 1990
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myelomaC Musolino, A Allegra, A Orlando, et al.
Medical Oncology (Northwood, London, England)|December 17, 2009
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemiaA Alonci, A Allegra, G Bellomo, et al.
American Journal of Hematology|May 1, 1993
Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemiaC Musolino, P Grosso, A Alonci, et al.
American Journal of Hematology|May 1, 1994
Effective therapy of aplastic anaemia post-hepatitis with recombinant human erythropoietinC Musolino, A Orlando, A Alonci, et al.
Journal of Neurosurgical Sciences|March 1, 1994
Combined systemic beta-interferon and thymostimulin administration for metastatic brain tumors. A brief reportF M Salpietro, S Cipri, C Alafaci, et al.
Acta Haematologica|January 1, 1991
Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemiaC Musolino, E Di Cesare, A Alonci, et al.
European Journal of Cancer Care|July 4, 2017
Standardisation of minimal residual disease in multiple myelomaV Innao, A Allegra, S Russo, et al.
Pageof 3